GH3-56768-34016
3 vaccinations
5 coded responses
34 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 506 / IA
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-15
Registered in v-safe
-
2021-02-15
Dose 1 — Pfizer-BioNTech
- 2021-02-15
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body achesAdult check-in
-
2021-02-18
Survey response — days 1–6 daily, dose 1MedDRA: Neck pain, Office visit — Feeling: Good · Headache · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Neck pain · Healthcare visit (other): ChiropractorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-01
-
2021-03-08
Dose 2 — Pfizer-BioNTech
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-21
- 2021-06-09
- 2021-08-06
- 2021-09-06
-
2021-12-09
Dose 3 — Pfizer-BioNTech
- 2021-12-09
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-11
- 2021-12-15
- 2021-12-18
-
2022-01-06
Survey response — day 28, dose 3MedDRA: Headache, Malaise — Feeling: FairFree text: Headache, malaiseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — day 35, dose 3MedDRA: Headache, Malaise — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache, malaiseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Survey response — day 42, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
- 2022-03-12
-
2022-06-10
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Head coldMedDRA releases: 2024-11 · check-in free text available
- 2022-12-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-15 | Pfizer-BioNTech | |
| 2 | 2021-03-08 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — days 1–6 daily, dose 1
Release 10 — day 28, dose 3
Symptoms: Headache, malaise
Release 10 — day 35, dose 3
Symptoms: Headache, malaise
Release 10 — day 42, dose 3
Symptoms: COVID
Release 12 — 6 months, dose 3
Symptoms: Head cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release